AGEN
NASDAQ · Biotechnology
Agenus Inc
$9.43
+0.89 (+10.42%)
Open$8.71
Previous Close$8.54
Day High$9.71
Day Low$8.47
52W High$8.85
52W Low$2.71
Volume—
Avg Volume940.0K
Market Cap389.52M
P/E Ratio4.23
EPS$2.65
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+304.3% upside
Current
$9.43
$9.43
Target
$38.13
$38.13
$23.34
$38.13 avg
$40.06
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 175.18M | 166.48M | 22.23M |
| Net Income | 177.9K | 152.2K | -3,026,461 |
| Profit Margin | 0.1% | 0.1% | -13.6% |
| EBITDA | 138.91M | 125.42M | -4,014,681 |
| Free Cash Flow | — | — | -2,971,274 |
| Rev Growth | +5.2% | +5.2% | +14.5% |
| Debt/Equity | 0.41 | 0.41 | 0.41 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |